Hetero Drugs Limited

FDA inspection history across 2 sites, 2018 to 2025

3
Form 483s

Every document, by year

  • Form 483

2018: one Form 483; 2020: one Form 483; 2025: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–20Two Form 483s, at Mandal, India and Sangareddy district, India.
  2. 2018The longest 483 on file: 3 observations over 3 pages at Mandal, India.
  3. 2025One Form 483, at Sangareddy district, India.

Cited most

Across all Hetero Drugs Limited observations on file

The complete Hetero Drugs Limited file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2025-05-16483 Form 483$99
2020-02-14483 Form 483$99
2018-03-02483 Form 483$99

FEI number 3003510514 · most recent document May 16, 2025

About Hetero Drugs Limited

How many FDA Form 483s has Hetero Drugs Limited received?

FDA Intel has 3 Form 483s on file for Hetero Drugs Limited; the most recent is dated May 16, 2025.

When was Hetero Drugs Limited last inspected by FDA?

The most recent FDA inspection document on file for Hetero Drugs Limited is a Form 483 dated May 16, 2025, for the site in Sangareddy district, India.

What did FDA cite at Hetero Drugs Limited?

The regulations cited most in the observations on file for Hetero Drugs Limited are 21 CFR 211.160 (General requirements), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time; 21 CFR 211.192 (Production record review), 1 time.